[20200916]IF11648_医疗供应链和政策选择：数据挑战.pdf

https:/crsreports.congress.gov September 16, 2020Medical Supply Chains and Policy Options: The Data ChallengeThe Coronavirus Disease 2019 (COVID-19) pandemic has revealed some areas in which the United States relies heavily on global supply chains. U.S. shortages of critical supplies of medical products have prompted congressional interest in better understanding U.S. import trends and domestic production capacity in certain industries considered essential to U.S. public health and national security. Some Members of Congress and the Trump Administration have sought ways to increase U.S. production of medical products, such as personal protective equipment (PPE) and pharmaceuticals, by providing economic incentives to firms and strengthening government procurement requirements to better prioritize domestically produced goods. Within this context, Congress has raised questions regarding domestic consumption of PPE and other medical products to understand the proportion of such goods that are produced domestically versus imported. Some Members have also sought a better understanding of the costs and feasibility of dismantlingand eventually reestablishing elsewheresome global supply c